FILE PHOTO: A medical worker handles a vial of the Pfizer-BioNTech Covid-19 vaccine at the Korian Samarobriva Ehpad (care home centre for ederly people) in Amiens, as the spread of the coronavirus disease (COVID-19) continues in France, January 7, 2021. REUTERS/Pascal Rossignol
BERLIN (Reuters) - France is delaying a European Union order for 1.8 billion doses of the BioNTech/Pfizer COVID-19 vaccine planned for the next two years, Germany's Die Welt daily newspaper reported on Friday, citing EU diplomats.
The paper said it was unclear what the reason was for hesitation from Paris, but diplomats had speculated that it might want French companies to play a bigger part in the vaccine production.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
